Use of high-capacity surface with oriented recombinant antibody fragments in a 5-min immunoassay for thyroid-stimulating hormone

Analytical Biochemistry

Volumn 396, Issue 2, 2010, Pages 242-249

  Brockmann, Eeva Christine ^a   Vehniäinen, Markus ^a   Pettersson, Kim ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Antibody immobilization; Immunoassay; Kinetics; Recombinant antibody fragment; TSH

Indexed keywords

ENZYME KINETICS; KINETICS; MONOCLONAL ANTIBODIES;

ANALYTICAL PERFORMANCE; ANTIBODY IMMOBILIZATION; BINDING CAPACITIES; IMMUNOASSAY; MONOCLONAL ANTIBODIES (MAB); RECOMBINANT ANTIBODY; THYROID STIMULATING HORMONES; TIME-RESOLVED FLUORESCENT MEASUREMENTS;

IMMUNOLOGY;

HETEROPHILE ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; REAGENT; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; THYROTROPIN;

ANTIGEN BINDING; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; INCUBATION TIME; INTERMETHOD COMPARISON; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STORAGE TEMPERATURE; SURFACE PROPERTY; THERMOSTABILITY; TIME;

EID: 70449720513     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.10.002     Document Type: Article

References (56)

1. Szkudlinski M.W., Fremont V., Ronin C., and Weintraub B.D. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol. Rev. 82 (2002) 473-502
2. Stockigt J.R. Case finding and screening strategies for thyroid dysfunction. Clin. Chim. Acta 315 (2002) 111-124
3. Tunbridge W.M., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., Evans J.G., Young E., Bird T., and Smith P.A. The spectrum of thyroid disease in a community: The Whickham Survey. Clin. Endocrinol. 7 (1977) 481-493
4. Sawin C.T., Castelli W.P., Hershman J.M., McNamara P., and Bacharach P. The aging thyroid: Thyroid deficiency in the Framingham Study. Arch. Intern. Med. 145 (1985) 1386-1388
5. Bagchi N., Brown T.R., and Parish R.F. Thyroid dysfunction in adults over age 55 years: A study in an urban community. Arch. Intern. Med. 150 (1990) 785-787
6. Schaaf L., Pohl T., Schmidt R., Vardali I., Teuber J., Schlote-Sauter B., Nowotny B., Schliebeler H., Zober A., and Usadel K.H. Screening for thyroid disorders in working population. Clin. Invest. 71 (1993) 126-131
7. Vanderpump M.P.J., Neary R.H., Manning K., and Clayton R.N. Does an increase in the sensitivity of serum thyrotropin assays reduce diagnostic costs for thyroid disease in the community?. J. R. Soc. Med. 90 (1995) 547-550
8. Bjøro T., Holmen J., Krüger Ø., Midthjell K., Hunstad K., Schreiner T., Sandnes L., and Brochmann H. Prevalence of thyroid disease, thyroid dysfunction, and thyroid peroxidase antibodies in a large, unselected population: The Health Study of Nord-Trønelag (HUNT). Eur. J. Endocrinol. 143 (2000) 639-647
9. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., and Braverman L.E. Serum TSH, T 4, and thyroid antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. 87 (2002) 489-499
10. Ladenson P.V., Singer P.A., Ain K.B., Bagchi N., Bigos S.T., Levy E.G., Smith S.A., and Daniels G.H. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch. Intern. Med. 160 (2000) 1573-1575
11. Hefland M., and Redfern C.C. Screening for thyroid disease. Ann. Intern. Med. 129 (1998) 144-158
12. Viera A.J. Thyroid function testing in outpatients: Are both sensitive thyrotropin (sTSH) and free thyroxine (FT 4) necessary?. Fam. Med. 35 (2003) 408-410
13. Spencer C.A., Takeuchi M., and Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin. Chem. 42 (1996) 140-145
14. Taimela E., Aalto M., Viikari J., Nuutila P., and Irjala K. Third generation time-resolved immunofluorometric TSH assay for automatic immunoassay system evaluated. Scand. J. Clin. Lab. Invest. 55 (1995) 537-541
15. Rawlins M.L., and Roberts W.L. Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin. Chem. 50 (2004) 2338-2344
16. Bjerner J., Nustad K., Norum L.F., Olsen K.H., and Børmer O.P. Immunometric assay interference. Incidence and prevention. Clin. Chem. 48 (2002) 613-621
17. Warren D.J., Bjerner J., Paus E., Børmer O.P., and Nustad K. Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies. Clin. Chem. 51 (2005) 830-838
18. Siegel R.W., Baugher W., Rahn T., Drengler S., and Tyner J. Affinity maturation of tacrolimus antibody for improved immunoassay performance. Clin. Chem. 54 (2008) 1008-1017
19. Lamminmäki U., Westerlund-Karlsson A., Toivola M., and Saviranta P. Modulating the binding properties of an anti-17(-estradiol antibody by systematic mutation combinations. Protein Sci. 12 (2003) 2549-2558
20. Harrison J.S., and Keshavarz-Moore E. Production of antibody fragments in Escherichia coli. Ann. N.Y. Acad. Sci. 782 (1996) 143-158
21. Vallina-García R., del Mar García-Suárez M., Fernández-Abedul M.T., Méndez F.J., and Costa-García A. Oriented immobilization of anti-pneumolysin Fab through a histidine tag for electrochemical immunosensors. Biosens. Bioelectron. 23 (2007) 210-217
22. Peluso P., Wilson D.S., Do D., Tran H., Venkatasubbaiah M., Quincy D., Heidecker B., Poindexter K., Tolani N., Phelan M., Witte K., Jung L.S., Wagner P., and Nock S. Optimizing antibody immobilization strategies for the construction of protein microarrays. Anal. Biochem. 312 (2003) 113-124
23. Välimaa L., Pettersson K., Vehniäinen M., Karp M., and Lövgren T. A high-capacity streptavidin-coated microtitration plate. Bioconj. Chem. 14 (2003) 103-111
24. Ylikotila J., Välimaa L., Vehniäinen M., Takalo H., Lövgren T., and Pettersson K. A sensitive TSH assay in spot-coated microwells utilizing recombinant antibody fragments. J. Immunol. Methods 306 (2005) 104-114
25. von Lode P., Hagrén V., Palenius T., and Lövgren T. One-step quantitative assay for the detection of hypothyroidism in point-of-care conditions. Clin. Biochem. 36 (2003) 121-128
26. Pelkkikangas A.M., Jaakohuhta S., Lövgren T., and Härmä H. Simple, rapid, and sensitive thyroid-stimulating hormone immunoassay using europium(III) nanoparticle label. Anal. Chim. Acta 517 (2004) 169-176
27. Eriksson S., Vehniäinen M., Jansen T., Meretoja V., Saviranta P., Pettersson K., and Lövgren T. Dual-label time-resolved immunofluorometric assay of free and total prostate-specific antigen based on recombinant Fab fragments. Clin. Chem. 46 (2000) 658-666
28. Härmä H., Tarkkinen P., Soukka T., and Lövgren T. Miniature single-particle immunoassay for prostate-specific antigen in serum using recombinant Fab fragments. Clin. Chem. 46 (2000) 1755-1761
29. Ylikotila J., Hellstrom J.L., Eriksson S., Vehniäinen M., Välimaa L., Takalo H., Bereznikova A., and Pettersson K. Utilization of recombinant Fab fragments in a cTnI immunoassay conducted in spot wells. Clin. Biochem. 39 (2006) 843-850
30. Korpimäki T., Hagren V., Brockmann E.-C., and Tuomola M. A generic lanthanide fluoroimmunoassay for the simultaneous screening of 18 sulfonamides using an engineered antibody. Anal. Chem. 76 (2004) 3091-3098
31. Pulli T., Höyhtyä M., Söderlund H., and Takkinen K. One-step homogeneous immunoassay for small analytes. Anal. Chem. 77 (2005) 2637-2642
32. Stenman U.-H. Improving immunoassay performance by antibody engineering. Clin. Chem. 51 (2005) 801-802
33. Lövgren T., Meriö L., Mitrunen K., Mäkinen M.L., Mäkelä M., Blomberg K., Palenius T., and Pettersson K. One-step all-in-one dry reagent immunoassays with fluorescent europium chelate label and time-resolved fluorometry. Clin. Chem. 42 (1996) 1196-1201
34. Qin Q.P., Christiansen M., and Pettersson K. Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: Use in first-trimester screening for Down syndrome. Clin. Chem. 48 (2002) 473-483
35. Qin Q.P., Peltola O., and Pettersson K. Time-resolved fluorescence resonance energy transfer assay for point-of-care testing of urinary albumin. Clin. Chem. 49 (2003) 1105-1113
36. Hedberg P., Ylitalo K., and Puukka M. Highly sensitive determination of C-reactive protein on the Innotrac Aio! immunoanalyzer. Scand. J. Clin. Lab. Invest. 64 (2004) 677-685
37. Vikstedt R., von Lode P., Takala T., Irjala K., Peltola O., Pettersson K., and Suominen P. Rapid one-step immunofluorometric assay for measuring soluble transferrin receptor in whole blood. Clin. Chem. 50 (2004) 1831-1833
38. von Lode P., Rainaho J., and Pettersson K. Quantitative, wide-range, 5-minute point-of-care immunoassay for total human chorionic gonadotropin in whole blood. Clin. Chem. 50 (2004) 1026-1035
39. von Lode P., Rosenberg J., Pettersson K., and Takalo H. A europium chelate for quantitative point-of-care immunoassays using direct surface measurement. Anal. Chem. 75 (2003) 3193-3201
40. Brockmann E.-C., Cooper M., Strömsten N., Vehniäinen M., and Saviranta P. Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions. J. Immunol. Methods 296 (2005) 159-170
41. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., and Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77 (1989) 51-59
42. Panyutich A.V., Baturevich E.A., Kolesnikova T.S., and Ganz T. The effect of biotinylation on the antigenic specificity of anti-defensin monoclonal antibodies. J. Immunol. Methods 158 (1993) 237-242
43. Saviranta P., Haavisto T., Rappu P., Karp M., and Lövgren T. In vitro enzymatic biotinylation of recombinant Fab fragments through a peptide acceptor tail. Bioconj. Chem. 9 (1998) 725-735
44. Vijayendran R.A., and Leckband D.E. A quantitative assessment of heterogeneity for surface-immobilized proteins. Anal. Chem. 73 (2001) 471-480
45. Birtalan S., Zhang Y., Fellouse F.A., Shao L., Schaefer G., and Sidhu S.S. The intrinsic contributions of tyrosine, serine, glycine, and arginine to the affinity and specificity of antibodies. J. Mol. Biol. 377 (2006) 1518-1528
46. Näreoja T., Vehniäinen M., Lamminmäki U., Hänninen P.E., and Härmä H. Study of nonspecificity of an immunoassay using Eu-doped polystyrene nanoparticle labels. J. Immunol. Methods 345 (2009) 80-89
47. Soukka T., Paukkunen J., Härmä H., Lönnberg S., Lindroos H., and Lövgren T. Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology. Clin. Chem. 47 (2001) 1269-1278
48. Arndt K.M., Müller K.M., and Plückthun A. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. Biochemistry 37 (1998) 12918-12926
49. Jäger M., and Plückthun A. Domain interactions in antibody Fv and scFv fragments: Effects on unfolding kinetics and equilibria. FEBS Lett. 462 (1999) 307-312
50. Scheuermann J., Vili F., and Neri D. Unexpected observation of concentration-dependent dissociation rates for antibody-antigen complexes and other macromolecular complexes in competition experiments. J. Immunol. Methods 276 (2003) 129-134
51. Ewert S., Huber T., Honegger A., and Plückthun A. Biophysical properties of human antibody variable domains. J. Mol. Biol. 325 (2003) 531-553
52. Röthlisberger D., Honegger A., and Plückthun A. Domain interactions in the Fab fragment: A comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. J. Mol. Biol. 347 (2005) 773-789
53. Wörn A., and Plückthun A. Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 305 (2001) 989-1010
54. A. Honegger, Engineering antibodies for stability and efficient folding, in: Y. Chernajovsky, A. Nissim (Eds.), Handbook of Experimental Pharmacology, vol. 181: Therapeutic Antibodies, Springer-Verlag, Berlin, 2008, pp. 47-68.
55. 1 monoclonal antibodies. J. Pharm. Sci. 97 (2008) 1414-1426
56. Morgan C.L., Newman D.J., Burrin J.M., and Price C.P. The matrix effects on kinetic rate constants of antibody-antigen interactions reflect solvent viscosity. J. Immunol. Methods 217 (1998) 51-60